(en) Lorena Fernández de la Cruz, Kayoko Isomura, Paul Lichtenstein et Henrik Larsson, « All cause and cause specific mortality in obsessive-compulsive disorder: nationwide matched cohort and sibling cohort study », The BMJ, vol. 384, , e077564 (ISSN0959-8138, PMID38233033, DOI10.1136/bmj-2023-077564, lire en ligne, consulté le )
(en) B.S. Peterson, « Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders in an epidemiological sample », J Am Acad Child Adolesc Psychiatry, vol. 40, no 6, , p. 685–695 (PMID11392347, DOI10.1097/00004583-200106000-00014)
Amitai Abramovitch, Gideon Anholt, Sagi Raveh-Gottfried et Naama Hamo, « Meta-Analysis of Intelligence Quotient (IQ) in Obsessive-Compulsive Disorder », Neuropsychology Review, vol. 28, no 1, , p. 111-120 (ISSN1573-6660, PMID28864868, DOI10.1007/s11065-017-9358-0, lire en ligne, consulté le )
(en) Tim Cadman, Debbie Spain, Patrick Johnston et Ailsa Russell, « Obsessive-Compulsive Disorder in Adults with High-Functioning Autism Spectrum Disorder: What Does Self-Report with the OCI-R Tell Us?: OCD in adults with ASD », Autism Research, vol. 8, no 5, , p. 477–485 (DOI10.1002/aur.1461, lire en ligne, consulté le ).
(en) da Rocha FF, Alvarenga NB, Malloy-Diniz L, Corrêa H, « Decision-making impairment in obsessive-compulsive disorder as measured by the Iowa Gambling Task », Arq Neuropsiquiatr, vol. 69, no 4, , p. 642-7. (PMID21877034, DOI10.1590/S0004-282X2011000500013, lire en ligne [html])modifier
(en) Kashyap H, Kumar JK, Kandavel T, Reddy YC, « Neuropsychological functioning in obsessive-compulsive disorder: are executive functions the key deficit? », Compr Psychiatry, vol. 54, no 5, , p. 533-40. (PMID23419731, DOI10.1016/j.comppsych.2012.12.003)modifier
(en) Cavedini P, Zorzi C, Piccinni M, Cavallini MC, Bellodi L, « Executive dysfunctions in obsessive-compulsive patients and unaffected relatives: searching for a new intermediate phenotype », Biol Psychiatry, vol. 67, no 12, , p. 1178-84. (PMID20381015, DOI10.1016/j.biopsych.2010.02.012)modifier
Robert M. Roth, Jacinthe Baribeau, Denise Milovan et Kieron O'Connor, « Procedural and declarative memory in obsessive-compulsive disorder », Journal of the International Neuropsychological Society: JINS, vol. 10, no 5, , p. 647-654 (ISSN1355-6177, PMID15327712, DOI10.1017/S1355617704105018, lire en ligne, consulté le )
João Flores Alves dos Santos et Luc Mallet, « Le trouble obsessionnel compulsif », Med Sci, vol. 29, no 12, , p. 1111-1116 (DOI10.1051/medsci/20132912014)
(en) STOC Study Group, « Subthalamic nucleus stimulation in severe obsessive-compulsive disorder - PubMed », The New England journal of medicine, vol. 359, no 20, , p. 2121-2134 (ISSN1533-4406, PMID19005196, DOI10.1056/NEJMoa0708514, lire en ligne, consulté le ).
P. Cialdella, « Réponse à Perron et al. concernant leur texte : « Quelques remarques méthodologiques à propos du rapport Inserm Psychothérapie. Trois approches évaluées » », L'Encéphale, vol. 33, no 5, , p. 783–790 (ISSN0013-7006, DOI10.1016/j.encep.2006.07.001)
(en) Afshar H, Roohafza H, Mohammad-Beigi H, Haghighi M, Jahangard L, Shokouh P, Sadeghi M, Hafezian H, « N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial », J Clin Psychopharmacol, vol. 32, no 6, , p. 797-803 (PMID23131885, DOI10.1097/JCP.0b013e318272677d)modifier
(en) Sayyah M, Boostani H, Pakseresht S, Malayeri A, « Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder », Prog Neuropsychopharmacol Biol Psychiatry, vol. 34, no 2, , p. 362-5 (PMID20035818, DOI10.1016/j.pnpbp.2009.12.016)modifier
(en) Lorena Fernández de la Cruz, Kayoko Isomura, Paul Lichtenstein et Henrik Larsson, « All cause and cause specific mortality in obsessive-compulsive disorder: nationwide matched cohort and sibling cohort study », The BMJ, vol. 384, , e077564 (ISSN0959-8138, PMID38233033, DOI10.1136/bmj-2023-077564, lire en ligne, consulté le )
Amitai Abramovitch, Gideon Anholt, Sagi Raveh-Gottfried et Naama Hamo, « Meta-Analysis of Intelligence Quotient (IQ) in Obsessive-Compulsive Disorder », Neuropsychology Review, vol. 28, no 1, , p. 111-120 (ISSN1573-6660, PMID28864868, DOI10.1007/s11065-017-9358-0, lire en ligne, consulté le )
(en) Alexandra Bottas, « Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? », Journal of psychiatry & neuroscience: JPN, vol. 30, no 3, , p. 187-193 (ISSN1180-4882, PMID15944743, PMCIDPMC1089779).
Robert M. Roth, Jacinthe Baribeau, Denise Milovan et Kieron O'Connor, « Procedural and declarative memory in obsessive-compulsive disorder », Journal of the International Neuropsychological Society: JINS, vol. 10, no 5, , p. 647-654 (ISSN1355-6177, PMID15327712, DOI10.1017/S1355617704105018, lire en ligne, consulté le )
(es) E. Fernández Córdoba et J. López-Ibor Aliño, « La monoclomiprana en fermos psiquiatricos resistentes a otros tratamientos », Actas Luso-Espanolas De Neurologia Y Psiquiatria, vol. 26, no 2, , p. 119-147 (ISSN0001-7329, PMID5628965)
(en) STOC Study Group, « Subthalamic nucleus stimulation in severe obsessive-compulsive disorder - PubMed », The New England journal of medicine, vol. 359, no 20, , p. 2121-2134 (ISSN1533-4406, PMID19005196, DOI10.1056/NEJMoa0708514, lire en ligne, consulté le ).
P. Cialdella, « Réponse à Perron et al. concernant leur texte : « Quelques remarques méthodologiques à propos du rapport Inserm Psychothérapie. Trois approches évaluées » », L'Encéphale, vol. 33, no 5, , p. 783–790 (ISSN0013-7006, DOI10.1016/j.encep.2006.07.001)
(en) Lorena Fernández de la Cruz, Kayoko Isomura, Paul Lichtenstein et Henrik Larsson, « All cause and cause specific mortality in obsessive-compulsive disorder: nationwide matched cohort and sibling cohort study », The BMJ, vol. 384, , e077564 (ISSN0959-8138, PMID38233033, DOI10.1136/bmj-2023-077564, lire en ligne, consulté le )
(en) Trifiletti R, Packard A, « Immune mechanisms in pediatric neuropsychiatric disorders: Tourette's syndrome, OCD, and Pandas » Child Adolesc Psychiatr, Clin N Am. 1999;8:767-775 PMID10553202
(en) B.S. Peterson, « Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders in an epidemiological sample », J Am Acad Child Adolesc Psychiatry, vol. 40, no 6, , p. 685–695 (PMID11392347, DOI10.1097/00004583-200106000-00014)
Amitai Abramovitch, Gideon Anholt, Sagi Raveh-Gottfried et Naama Hamo, « Meta-Analysis of Intelligence Quotient (IQ) in Obsessive-Compulsive Disorder », Neuropsychology Review, vol. 28, no 1, , p. 111-120 (ISSN1573-6660, PMID28864868, DOI10.1007/s11065-017-9358-0, lire en ligne, consulté le )
(en) Alexandra Bottas, « Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? », Journal of psychiatry & neuroscience: JPN, vol. 30, no 3, , p. 187-193 (ISSN1180-4882, PMID15944743, PMCIDPMC1089779).
(en) da Rocha FF, Alvarenga NB, Malloy-Diniz L, Corrêa H, « Decision-making impairment in obsessive-compulsive disorder as measured by the Iowa Gambling Task », Arq Neuropsiquiatr, vol. 69, no 4, , p. 642-7. (PMID21877034, DOI10.1590/S0004-282X2011000500013, lire en ligne [html])modifier
(en) Kashyap H, Kumar JK, Kandavel T, Reddy YC, « Neuropsychological functioning in obsessive-compulsive disorder: are executive functions the key deficit? », Compr Psychiatry, vol. 54, no 5, , p. 533-40. (PMID23419731, DOI10.1016/j.comppsych.2012.12.003)modifier
(en) Cavedini P, Zorzi C, Piccinni M, Cavallini MC, Bellodi L, « Executive dysfunctions in obsessive-compulsive patients and unaffected relatives: searching for a new intermediate phenotype », Biol Psychiatry, vol. 67, no 12, , p. 1178-84. (PMID20381015, DOI10.1016/j.biopsych.2010.02.012)modifier
(en) Demeter G, Racsmány M, Csigó K, Harsányi A, Németh A, Döme L, « Intact short-term memory and impaired executive functions in obsessive compulsive disorder », Ideggyogy Sz, vol. 66, nos 1-2, , p. 35-41. (PMID23607228)modifier
Robert M. Roth, Jacinthe Baribeau, Denise Milovan et Kieron O'Connor, « Procedural and declarative memory in obsessive-compulsive disorder », Journal of the International Neuropsychological Society: JINS, vol. 10, no 5, , p. 647-654 (ISSN1355-6177, PMID15327712, DOI10.1017/S1355617704105018, lire en ligne, consulté le )
(es) E. Fernández Córdoba et J. López-Ibor Aliño, « La monoclomiprana en fermos psiquiatricos resistentes a otros tratamientos », Actas Luso-Espanolas De Neurologia Y Psiquiatria, vol. 26, no 2, , p. 119-147 (ISSN0001-7329, PMID5628965)
(en) Abramowitz J. « The psychological treatment of obsessive-compulsive disorder » Can J Psychiatry 2006;51:407-416 PMID16838822
(en) Bloch M, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken M, Leckman J, « A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder » Mol Psychiatry 2006;11:622-632. PMID16585942
(en) STOC Study Group, « Subthalamic nucleus stimulation in severe obsessive-compulsive disorder - PubMed », The New England journal of medicine, vol. 359, no 20, , p. 2121-2134 (ISSN1533-4406, PMID19005196, DOI10.1056/NEJMoa0708514, lire en ligne, consulté le ).
(en) Jenike MA. « Obsessive-compulsive disorder: efficacy of specific treatments as assessed by controlled trials » Psychopharmacol Bull. 1993;29(4):487-99. PMID8084980
(en) Perrine DM, « Hallucinogens and obsessive-compulsive disorder », Am J Psychiatry, vol. 156, no 7, , p. 1123 (PMID10401480)modifier
(en) Tizabi Y, Louis VA, Taylor CT, Waxman D, Culver KE, Szechtman H, « Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive-compulsive disorder », Biol Psychiatry, vol. 51, no 2, , p. 164-71 (PMID11822995)modifier
(en) Salín-Pascual RJ, Basañez-Villa E, « Changes in compulsion and anxiety symptoms with nicotine transdermal patches in non-smoking obsessive-compulsive disorder patients », Rev Invest Clin, vol. 55, no 6, , p. 650-4 (PMID15011734)modifier
(en) Pasquini M, Garavini A, Biondi M, « Nicotine augmentation for refractory obsessive-compulsive disorder. A case report », Prog Neuropsychopharmacol Biol Psychiatry, vol. 29, no 1, , p. 157-9 (PMID15610960)modifier
(en) Lundberg S, Carlsson A, Norfeldt P, Carlsson ML, « Nicotine treatment of obsessive-compulsive disorder », Prog Neuropsychopharmacol Biol Psychiatry, vol. 28, no 7, , p. 1195-9 (PMID15610934)modifier
(en) Afshar H, Roohafza H, Mohammad-Beigi H, Haghighi M, Jahangard L, Shokouh P, Sadeghi M, Hafezian H, « N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial », J Clin Psychopharmacol, vol. 32, no 6, , p. 797-803 (PMID23131885, DOI10.1097/JCP.0b013e318272677d)modifier
(en) Sayyah M, Boostani H, Pakseresht S, Malayeri A, « Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder », Prog Neuropsychopharmacol Biol Psychiatry, vol. 34, no 2, , p. 362-5 (PMID20035818, DOI10.1016/j.pnpbp.2009.12.016)modifier
(en) da Rocha FF, Alvarenga NB, Malloy-Diniz L, Corrêa H, « Decision-making impairment in obsessive-compulsive disorder as measured by the Iowa Gambling Task », Arq Neuropsiquiatr, vol. 69, no 4, , p. 642-7. (PMID21877034, DOI10.1590/S0004-282X2011000500013, lire en ligne [html])modifier
(en) Öst L-G, Havnen A, Hansen B, Kvale G, « Cognitive behavioral treatments of obsessive–compulsive disorder. A systematic review and meta-analysis of studies published 1993–2014 », Clinical Psychology Review 40, (lire en ligne)
(en) da Rocha FF, Alvarenga NB, Malloy-Diniz L, Corrêa H, « Decision-making impairment in obsessive-compulsive disorder as measured by the Iowa Gambling Task », Arq Neuropsiquiatr, vol. 69, no 4, , p. 642-7. (PMID21877034, DOI10.1590/S0004-282X2011000500013, lire en ligne [html])modifier
(en) Kashyap H, Kumar JK, Kandavel T, Reddy YC, « Neuropsychological functioning in obsessive-compulsive disorder: are executive functions the key deficit? », Compr Psychiatry, vol. 54, no 5, , p. 533-40. (PMID23419731, DOI10.1016/j.comppsych.2012.12.003)modifier
(en) Cavedini P, Zorzi C, Piccinni M, Cavallini MC, Bellodi L, « Executive dysfunctions in obsessive-compulsive patients and unaffected relatives: searching for a new intermediate phenotype », Biol Psychiatry, vol. 67, no 12, , p. 1178-84. (PMID20381015, DOI10.1016/j.biopsych.2010.02.012)modifier
(en) Demeter G, Racsmány M, Csigó K, Harsányi A, Németh A, Döme L, « Intact short-term memory and impaired executive functions in obsessive compulsive disorder », Ideggyogy Sz, vol. 66, nos 1-2, , p. 35-41. (PMID23607228)modifier
(en) Perrine DM, « Hallucinogens and obsessive-compulsive disorder », Am J Psychiatry, vol. 156, no 7, , p. 1123 (PMID10401480)modifier
(en) Tizabi Y, Louis VA, Taylor CT, Waxman D, Culver KE, Szechtman H, « Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive-compulsive disorder », Biol Psychiatry, vol. 51, no 2, , p. 164-71 (PMID11822995)modifier
(en) Salín-Pascual RJ, Basañez-Villa E, « Changes in compulsion and anxiety symptoms with nicotine transdermal patches in non-smoking obsessive-compulsive disorder patients », Rev Invest Clin, vol. 55, no 6, , p. 650-4 (PMID15011734)modifier
(en) Pasquini M, Garavini A, Biondi M, « Nicotine augmentation for refractory obsessive-compulsive disorder. A case report », Prog Neuropsychopharmacol Biol Psychiatry, vol. 29, no 1, , p. 157-9 (PMID15610960)modifier
(en) Lundberg S, Carlsson A, Norfeldt P, Carlsson ML, « Nicotine treatment of obsessive-compulsive disorder », Prog Neuropsychopharmacol Biol Psychiatry, vol. 28, no 7, , p. 1195-9 (PMID15610934)modifier
(en) Afshar H, Roohafza H, Mohammad-Beigi H, Haghighi M, Jahangard L, Shokouh P, Sadeghi M, Hafezian H, « N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial », J Clin Psychopharmacol, vol. 32, no 6, , p. 797-803 (PMID23131885, DOI10.1097/JCP.0b013e318272677d)modifier
(en) Sayyah M, Boostani H, Pakseresht S, Malayeri A, « Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder », Prog Neuropsychopharmacol Biol Psychiatry, vol. 34, no 2, , p. 362-5 (PMID20035818, DOI10.1016/j.pnpbp.2009.12.016)modifier
(en) Tim Cadman, Debbie Spain, Patrick Johnston et Ailsa Russell, « Obsessive-Compulsive Disorder in Adults with High-Functioning Autism Spectrum Disorder: What Does Self-Report with the OCI-R Tell Us?: OCD in adults with ASD », Autism Research, vol. 8, no 5, , p. 477–485 (DOI10.1002/aur.1461, lire en ligne, consulté le ).
